Form D · Pharmaceuticals
EFFRX PHARMACEUTICALS SA
Freienbach, V8 · CIK 0001494588
Offering snapshot reported Jul 5, 2012 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 5, 2012 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Jul 2, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-180737
Source: Form D, filed Jul 5, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Oscar Ahlgren | Director |
| Yvonne Gunsch Wegmann | Executive |
| Marshall Hayward | Executive |
| Cg Johansson | Director |
| Jesper Parnevik | Director |
| Christer Rosen | Director, Executive |
| Christer Roser | Director |
| Fritz Schneiter | Director |
| Friedrich Schneiter | Director |
| Jacob Uittenbogaard | Director |
| Anders Wiklund | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Wolleraustrasse 41 B
Freienbach, V8, CH-8807
Freienbach, V8, CH-8807